Poor hormone receptor expression in East African breast cancer: Evidence of a biologically different disease?

Annals of Surgical Oncology

Volumn 15, Issue 7, 2008, Pages 1983-1988

  Bird, P A ^a   Hill, A G ^b   Houssami, N ^c  

^a AIC KIJABE HOSPITAL   (Kenya)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Africa; Cancer biology; Her2; Hormone sensitivity; Locally advanced breast cancer; Oestrogen receptor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ADVANCED CANCER; AFRICA; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST DUCT; BREAST RECONSTRUCTION; CANCER GRADING; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; EVIDENCE BASED MEDICINE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; MENOPAUSE; PARITY; PROTEIN EXPRESSION;

ADULT; AFRICA, EASTERN; AGED; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 46149087263     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9900-7     Document Type: Article

References (13)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108
2. Eniu A, Carlson RW, Aziz Z, et al. Breast cancer in limited-resource countries: treatment and allocation of resources. Breast J 2006; 12:S38-53
3. Nyagol J, Nyong'o A, Byakika B, et al. Routine assessment of hormonal receptor and her-2/neu status underscores the need for more therapeutic targets in Kenyan women with breast cancer. Anal Quant Cytol Histol 2006; 28:97-103
4. Ikpatt OF, Ndoma-Egba R. Oestrogen and progesterone receptors in Nigerian breast cancer: relationship to tumour histology and survival of patients. Cent Afr J Med 2003; 49:122-6
5. Mbonde MP, Amir H, Schwartz-Albiez R, et al. Expression of estrogen and progesterone receptors in carcinomas of the female breast in Tanzania. Oncol Rep 2000; 7:277-83
6. Anderson BO, Shyyan R, Eniu A, et al. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J 2006; 12:S3-15
7. Henson DE, Chu KC, Levine PH. Histological grade, stage and survival in breast carcinoma. Comparison of African American and Caucasian women. Cancer 2003; 98:908-17
8. International Agency for Research on Cancer (IARC): GLOBOCAN 2002 database (accessed 03/01/2008): http://www-dep.iarc.fr
9. Fregene A, Newman LA. Breast cancer in sub-Saharan Africa: How does it relate to breast cancer in African-American women? Cancer 2005; 103:1540-50
10. Chu KC, Anderson WF. Rates for breast cancer characteristics by oestrogen and progesterone receptor status in the major racial/ethnic groups. Breast Cancer Res Treat 2002; 74:199-211
11. Chu KC, Anderson WF, Fritz A, et al. Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer 2001; 92:37-45
12. Siziopikou KP, Cobleigh M. The basal subtype of breast carcinomas may represent the group of breast tumours that could benefit from EGFR-targeted therapies. Breast 2007; 16:104-7
13. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006; 295:2492-502